At the 2.4 mg maximum dose, patients typically experience sustained appetite suppression and enhanced satiety that supports long-term weight management
The glucagon-like peptide-1 receptor--or not
The decision to continue, adjust, or discontinue therapy should be based on objective body composition measurements (DEXA scans, circumference measurements), achievement of fat loss goals, tolerance and side effect profile, and physician assessment of metabolic markers
How much does it cost to replace semaglutide if it's damaged from improper storage
What makes Retatrutide different
If You Have Pre-Existing Thyroid Conditions If you have hypothyroidism and take levothyroxine, your provider may recommend checking TSH and free T4 levels more frequently during the first few months of GLP-1 therapy and after significant weight loss